The America Invents Act: Changes in the Patent Laws of Special Interest to the Life Sciences Industry
Reproduced with permission from Life Sciences Law & Industry Report. Copyright © 2011 by The Bureau of National Affairs, Inc.
After several years of unsuccessful attempts, Congress recently passed the Leahy-Smith America Invents Act (the ‘‘AIA’’), containing the most significant changes to the Patent Act in more than 60 years. President Obama signed the AIA into law on Sept. 16.This article presents an overview of the major provisions that are significant for practitioners in the life sciences.
1 H.R. 1249 (112th Congress).
2 Pub. L. No. 112-29.
3 The authors recognize that there is no monolithic ‘‘life sciences industry’’ that speaks with one voice on all issues, but instead use this term to address views that may be common or shared among individuals and entities advancing or using technologies in the biomedical or biotechnological sciences.
Read the full article by clicking the link below.
The America Invents Act: Changes in the Patent Laws of Special Interest to the Life Sciences Industry
The articles on our Web site include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice or as an expression of the views of the firm, its attorneys or any of its clients. We hope the articles spur discussion in the legal community with insight into the experience of the authors. We expressly reserve the right in the future to become wiser or simply change our mind.